MIRXES Trademark

Trademark Overview


On Friday, November 18, 2016, a trademark application was filed for MIRXES with the United States Patent and Trademark Office. The USPTO has given the MIRXES trademark a serial number of 79207058. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, October 3, 2024. This trademark is owned by MIRXES PTE. LTD.. The MIRXES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes, namely, reactants for medical and veterinary diagnosis; medical diagnostic kit consisting primarily of diagnostic preparations for medical use; diagnostic products for medical purposes, namely, blood test kits consisting primarily of medical diagnostic reagents and test strips for the diagnosis of cancer, cardiovascular disorders, metabolic disorders, neurological disorders and immune disorders; biological indicators for medical diagnosis; veterinary diagnostic reagents; medical diagnostic kit consisting primarily of diagnostic reagents for medical and veterinary purposes for conducting Real Time Polymerase Chain Reaction assays (RT-PCR); chemical reagents for medical or veterinary laboratory purposes; medical and veterinary diagnostic reagents for use in testing the presence of cancer, cardiovascular disorders, metabolic disorders, neurological disorders and immune disor...

Research and development of technology in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture; research and development of new products; research and development in the field of microRNA; research and development in the field of microorganisms and cells; research relating to molecular sciences; provision of information and data relating to medical and veterinary research and development; research and development services in the field of antibody technology; research and development services in the field of cell therapy; research and development services in the field of in-vitro fertilization; research and development services in the field of neurodegenerative diseases; research and development services in the field of gene expression systems; chemical laboratory services; laboratory testing of blood, biofluids, stem cells, cancer cells, plants, plant seeds and crop seeds for research; contrac...
mirxes

General Information


Serial Number79207058
Word MarkMIRXES
Filing DateFriday, November 18, 2016
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, October 3, 2024
Registration Number5440477
Registration DateTuesday, April 10, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2018

Trademark Statements


Goods and ServicesDiagnostic preparations for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes, namely, reactants for medical and veterinary diagnosis; medical diagnostic kit consisting primarily of diagnostic preparations for medical use; diagnostic products for medical purposes, namely, blood test kits consisting primarily of medical diagnostic reagents and test strips for the diagnosis of cancer, cardiovascular disorders, metabolic disorders, neurological disorders and immune disorders; biological indicators for medical diagnosis; veterinary diagnostic reagents; medical diagnostic kit consisting primarily of diagnostic reagents for medical and veterinary purposes for conducting Real Time Polymerase Chain Reaction assays (RT-PCR); chemical reagents for medical or veterinary laboratory purposes; medical and veterinary diagnostic reagents for use in testing the presence of cancer, cardiovascular disorders, metabolic disorders, neurological disorders and immune disorders; pharmaceutical preparations for the treatment of disorders of the metabolic system; medical diagnostic reagents for testing of body fluids; stem cells for medical and veterinary purposes; substances for use in genetic probe assay kits, namely, medical diagnostic reagents, for medical use; diagnostic preparations for medical purposes; biochemical preparations for diagnostic use, namely, for use in testing the presence of cancer, cardiovascular disorders, metabolic disorders, neurological disorders and immune disorders; products for medical diagnosis, namely, blood test kits consisting primarily of medical diagnostic reagents and test strips for diagnosis of cancer, cardiovascular disorders, metabolic disorders, neurological disorders and immune disorders; diagnostic agents for medical use; test reagents for medical diagnostic use; diagnostic biomarker reagents for medical purposes; chemical preparations for medical diagnostic purposes; chemical preparations for medical use in DNA analysis; chemical products in the nature of biomarker discovery solutions for medical diagnosis and analysis; biological preparations for medical use in the analysis of cell cultures; medical diagnostic preparations for detecting genetic predispositions for medical purposes; medical diagnostic reagents for analytical purposes; synthetic deoxyribonucleic acid and synthetic ribonucleic acid for medical use; nucleic acid amplification reagents for medical use
Goods and ServicesResearch and development of technology in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture; research and development of new products; research and development in the field of microRNA; research and development in the field of microorganisms and cells; research relating to molecular sciences; provision of information and data relating to medical and veterinary research and development; research and development services in the field of antibody technology; research and development services in the field of cell therapy; research and development services in the field of in-vitro fertilization; research and development services in the field of neurodegenerative diseases; research and development services in the field of gene expression systems; chemical laboratory services; laboratory testing of blood, biofluids, stem cells, cancer cells, plants, plant seeds and crop seeds for research; contract scientific research in the field of molecular sciences; laboratory analysis in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture for research; laboratory research in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture; conducting scientific research in the nature of clinical trials for others in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering polymerase chain reactions, agriculture, botany and horticulture; laboratory research services relating to the field of microRNA technology; biological and biochemical analysis; bioinformatics analysis; veterinary laboratory services; scientific research and development; scientific analysis in the field of molecular biology; scientific research for medical purposes in the area of cancerous diseases; scientific structural and functional analysis of genomes; agricultural research services; scientific laboratory services for agricultural research; biotechnological research relating to agriculture; scientific research in the field of stem cell research; development and testing of computing methods, algorithms computer networks and computer software for others; providing testing and preparation services in relation to immunohistological samples for analysis in research laboratories; technical diagnostic testing services in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture for research; genetic testing for scientific research purposes; medical research services; biomedical research services; biochemistry research services; DNA testing services for scientific research purposes; DNA screening for scientific research purposes; pharmaceutical research services; biological research and analysis; biochemical research and analysis; scientific laboratory services; scientific and technical analysis in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture; technical data analysis services in the field of microRNA, DNA, molecular biology, biochemistry, genetic engineering, polymerase chain reactions, agriculture, botany and horticulture for research; medical research services featuring the analysis of tissues; environmental testing and inspection services; technical consultancy in the field of environmental science; research in the field of environmental protection; providing advisory and consultation services in connection with product testing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, May 13, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMIRXES PTE. LTD.
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressSingapore 618305
SG

Party NameMIRXES PTE. LTD.
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressSingapore 618305
SG

Party NameMIRXES PTE. LTD.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressSingapore 618305
SG

Trademark Events


Event DateEvent Description
Thursday, May 18, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 11, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, May 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 13, 2017ASSIGNED TO EXAMINER
Wednesday, May 17, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, May 17, 2017NON-FINAL ACTION WRITTEN
Saturday, December 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 2, 2017REFUSAL PROCESSED BY MPU
Friday, June 2, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 24, 2017REFUSAL PROCESSED BY IB
Wednesday, August 23, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 23, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 6, 2017ASSIGNED TO LIE
Saturday, December 9, 2017ASSIGNED TO LIE
Saturday, December 9, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, December 9, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 19, 2018NOTIFICATION PROCESSED BY IB
Monday, December 18, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, December 18, 2017EXAMINERS AMENDMENT E-MAILED
Monday, December 18, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 18, 2017EXAMINER'S AMENDMENT ENTERED
Monday, December 18, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 3, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 3, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 23, 2018PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, July 10, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, July 27, 2018FINAL DISPOSITION PROCESSED
Friday, July 27, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 24, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 23, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, March 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 30, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 3, 2024REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, October 3, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Saturday, September 17, 2022NEW REPRESENTATIVE AT IB RECEIVED
Monday, April 10, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, January 31, 2024TEAS SECTION 71 & 15 RECEIVED